TTX-114

N/A

Report date: 2023/05/24 16:16:00
NME

Base Information

Drug NameTTX-114
Drug Alias NameTTX-114
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase BTK inhibitors
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsHematologic NeoplasmsLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTrueline Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTrueline Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHematologic NeoplasmsLymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A